Inventor · disambiguated record
Isidro Hotzel
Also filed as: HOTZEL ISIDRO
18 granted patents·11 pending applications·23 citations·filing 2011–2025
90Inventor score
Top patents by PatentIndex Score
29 records- 0193US10112990B2Anti-Tau antibodies and methods of useGENENTECH INC·Filed 2016·Granted Oct 30, 2018·7 cites·106 claims
- 0292US10711058B2Anti-Tau antibodies and methods of useAC IMMUNE SA·Filed 2019·Granted Jul 14, 2020·7 cites·42 claims
- 0385US2024383984A1HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USEGENENTECH INC·Filed 2024·Application pending·0 cites
- 0484US12486319B2Anti-tau antibodies and methods of useGENENTECH INC·Filed 2022·Granted Dec 2, 2025·0 cites·17 claims
- 0583US2024043831A1Expression and secretion systemGENENTECH INC·Filed 2023·Application pending·0 cites
- 0682US10308944B2Polypeptide expression systemsGENENTECH INC·Filed 2015·Granted Jun 4, 2019·3 cites·47 claims
- 0779US10323094B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2016·Granted Jun 18, 2019·2 cites·24 claims
- 0878US9598485B2Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2014·Granted Mar 21, 2017·4 cites·66 claims
- 0977US12030947B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2021·Granted Jul 9, 2024·0 cites·70 claims
- 1077US2025333723A1Expression and secretion systemGENENTECH INC·Filed 2025·Application pending·0 cites
- 1175US11555065B2Anti-Tau antibodies and methods of useGENENTECH INC·Filed 2020·Granted Jan 17, 2023·0 cites·17 claims
- 1272US11192950B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2019·Granted Dec 7, 2021·0 cites·38 claims
- 1372US10633436B2Anti-tau antibodies and methods of useGENENTECH INC·Filed 2019·Granted Apr 28, 2020·0 cites·20 claims
- 1472US2023043289A1Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 1571US10336819B2Anti-Tau antibodies and methods of useGENENTECH INC·Filed 2018·Granted Jul 2, 2019·0 cites·85 claims
- 1671US10329344B2Anti-Tau Antibodies and methods of useGENENTECH INC·Filed 2018·Granted Jun 25, 2019·0 cites·78 claims
- 1770US2020385704A1Expression and secretion systemGENENTECH INC·Filed 2020·Application pending·0 cites
- 1869US11427629B2Anti-Tau antibodies and methods of useAC IMMUNE SA·Filed 2020·Granted Aug 30, 2022·0 cites·32 claims
- 1967US10633650B2Expression and secretion systemGENENTECH INC·Filed 2017·Granted Apr 28, 2020·0 cites·19 claims
- 2065US9803191B2Expression and secretion systemGENENTECH INC·Filed 2013·Granted Oct 31, 2017·0 cites·39 claims
- 2161US11851661B2Polypeptide expression systemsGENENTECH INC·Filed 2019·Granted Dec 26, 2023·0 cites·57 claims
- 2254US2015376265A1Antibody compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2353US12384844B2Agonists of TREM2GENENTECH INC·Filed 2022·Granted Aug 12, 2025·0 cites·42 claims
- 2452US9580514B2Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2013·Granted Feb 28, 2017·0 cites·16 claims
- 2548US2014328849A1Anti-crth2 antibodies and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2646US2012082666A1Antibody compositions and methods of useCHEN XIAOCHENG·Filed 2011·Application pending·0 cites
- 2745US2018021450A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2840US2018125995A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2938US2016090422A1Anti-crth2 antibodies and methods of useGENENTECH INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →